Form 4: Arvinas Chief Scientific Officer Sells Shares for Tax Obligations

Arvinas Chief Scientific Officer Angela M. Cacace sold 2,583 shares of common stock at $7.49 per share to cover tax withholding obligations related to RSU vesting.

Summary

• Angela M. Cacace, Chief Scientific Officer of Arvinas, Inc. (ARVN), reported a transaction on June 17, 2025.
• She disposed of 2,583 shares of Arvinas common stock.
• The shares were sold at a price of $7.49 per share.
• This sale was an automatic transaction executed by the Issuer to cover tax withholding obligations.
• The tax obligations arose from the vesting and settlement of 50% of her restricted stock units (RSUs) that were granted on June 17, 2024.
• Following this transaction, Ms. Cacace beneficially owns 154,248 shares of Arvinas common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale of shares to cover tax withholding obligations related to RSU vesting, which is a neutral event for company sentiment.

Positives

• The sale was non-discretionary, specifically made to cover tax withholding obligations, indicating it is not a signal of a lack of confidence in the company by the insider.

Negatives

• No direct negatives identified as the sale was for routine tax purposes.

Risks

• NA

Future Outlook

NA

Management Comments

• "This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of 50% of the reporting person's restricted stock units (RSUs) granted on June 17, 2024."

Industry Context

This Form 4 filing is a standard disclosure for insider transactions, common across all publicly traded companies, and does not provide specific industry context beyond the company's operations.

Comparison to Industry Standards

• NA

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders: The sale represents a minor, routine disposition of shares by an insider, which is a standard part of equity compensation and generally has minimal impact on the overall share structure.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• NA

Key Dates

Keywords

Arvinas, ARVN, insider trading, Form 4, stock sale, RSU, restricted stock units, tax withholding, Angela M. Cacace, Chief Scientific Officer